NO20071704L - Prostaglandinderivater for behandling av gastrointestinal forstyrrelse - Google Patents

Prostaglandinderivater for behandling av gastrointestinal forstyrrelse

Info

Publication number
NO20071704L
NO20071704L NO20071704A NO20071704A NO20071704L NO 20071704 L NO20071704 L NO 20071704L NO 20071704 A NO20071704 A NO 20071704A NO 20071704 A NO20071704 A NO 20071704A NO 20071704 L NO20071704 L NO 20071704L
Authority
NO
Norway
Prior art keywords
treatment
gastrointestinal disorder
effective
prostaglandin derivatives
present
Prior art date
Application number
NO20071704A
Other languages
English (en)
Other versions
NO340989B1 (no
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35229739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20071704(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20071704L publication Critical patent/NO20071704L/no
Publication of NO340989B1 publication Critical patent/NO340989B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Den foreliggende oppfmnelse vedrører en fremgangsmåte for langtidsbehandling av mageog tarmkanalforstyrrelser hos et menneske, som omfatter å administrere en effektiv mengde av en halogenert prostaglandinforbindelse og/eller dens tautomer til individet. Fremgangsmåten induserer i det vesentlige ikke noe elektrolyttskifte under behandlingstiden. Forbindelsene som anvendes ved den foreliggende oppfinnelse, kan forbedre livskvalitet hos menneskene med mage- og tarmkanalforstyrrelser, er like effektive ved behandling av menn og kvinner, og er også effektive hos et menneske til og med i alderen 65 år og eldre.
NO20071704A 2004-09-02 2007-03-30 Farmasøytisk sammensetning som omfatter en prostaglandinforbindelse for behandling av forstoppelse for å forbedre livskvaliteten hos et menneske, samt anvendelse av en prostaglandinforbindelse ved fremstilling av en farmasøytisk sammensetning for langtidsbehandling av forstoppelse for å forbedre livskvaliteten hos et menneske. NO340989B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60652104P 2004-09-02 2004-09-02
US66631705P 2005-03-30 2005-03-30
US66659305P 2005-03-31 2005-03-31
PCT/JP2005/016464 WO2006025599A1 (en) 2004-09-02 2005-09-01 Prostaglandin derivatives for treating gastrointestinal disorder

Publications (2)

Publication Number Publication Date
NO20071704L true NO20071704L (no) 2007-05-31
NO340989B1 NO340989B1 (no) 2017-07-31

Family

ID=35229739

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071704A NO340989B1 (no) 2004-09-02 2007-03-30 Farmasøytisk sammensetning som omfatter en prostaglandinforbindelse for behandling av forstoppelse for å forbedre livskvaliteten hos et menneske, samt anvendelse av en prostaglandinforbindelse ved fremstilling av en farmasøytisk sammensetning for langtidsbehandling av forstoppelse for å forbedre livskvaliteten hos et menneske.

Country Status (16)

Country Link
US (2) US8748481B2 (no)
EP (1) EP1791545B1 (no)
JP (4) JP2008511541A (no)
KR (4) KR20170003712A (no)
CN (1) CN102885821A (no)
AR (1) AR050626A1 (no)
AU (1) AU2005278323B2 (no)
BR (1) BRPI0514891A (no)
CA (1) CA2577284A1 (no)
ES (1) ES2603381T3 (no)
IL (1) IL181332A (no)
MX (1) MX2007002602A (no)
NO (1) NO340989B1 (no)
NZ (1) NZ553434A (no)
TW (1) TWI387454B (no)
WO (1) WO2006025599A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE539756T1 (de) * 2002-10-23 2012-01-15 Sucampo Ag Prostaglandinsubstanzen für die behandlung von fettsucht
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
AU2007208637B2 (en) * 2006-01-24 2012-04-26 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
US20090030072A1 (en) 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
JP2015514681A (ja) * 2012-04-23 2015-05-21 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 下痢を伴う過敏性腸症候群の処置方法
CN104955481B (zh) 2013-02-04 2017-10-24 大正制药株式会社 便秘症的预防或治疗药
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5428062A (en) 1987-01-28 1995-06-27 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
DE60010913T2 (de) 1999-10-15 2005-06-09 Sucampo Ag Bizyklische Verbindungen, Zusammenstellung und Verfahren zu ihrer Stabilisierung
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
KR100867295B1 (ko) 2001-05-18 2008-11-06 수캄포 아게 하제 조성물
NZ531503A (en) 2001-08-31 2006-01-27 Sucampo Ag Prostaglandin analogs as chloride channel opener
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
AU2003292556B2 (en) * 2002-12-27 2009-09-10 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
DE602004030245D1 (de) 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner

Also Published As

Publication number Publication date
IL181332A (en) 2015-09-24
AU2005278323B2 (en) 2011-03-17
CN102885821A (zh) 2013-01-23
EP1791545B1 (en) 2016-08-31
TWI387454B (zh) 2013-03-01
AU2005278323A1 (en) 2006-03-09
KR20070048221A (ko) 2007-05-08
US20060063830A1 (en) 2006-03-23
AR050626A1 (es) 2006-11-08
KR20140019006A (ko) 2014-02-13
NZ553434A (en) 2010-01-29
CA2577284A1 (en) 2006-03-09
WO2006025599A1 (en) 2006-03-09
KR20170003712A (ko) 2017-01-09
KR20180033310A (ko) 2018-04-02
US8748481B2 (en) 2014-06-10
US20140315994A1 (en) 2014-10-23
ES2603381T3 (es) 2017-02-27
JP2015166377A (ja) 2015-09-24
IL181332A0 (en) 2007-07-04
JP2008511541A (ja) 2008-04-17
JP6408426B2 (ja) 2018-10-17
NO340989B1 (no) 2017-07-31
MX2007002602A (es) 2007-04-25
JP2013049688A (ja) 2013-03-14
JP2018150354A (ja) 2018-09-27
TW200612901A (en) 2006-05-01
BRPI0514891A (pt) 2008-06-24
EP1791545A1 (en) 2007-06-06

Similar Documents

Publication Publication Date Title
NO20071704L (no) Prostaglandinderivater for behandling av gastrointestinal forstyrrelse
MY144750A (en) Treatment method
NO20070247L (no) Amino-5,5-difenylimidazolonderivater for inhibisjon av beta-sekretase
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
BRPI0416212A (pt) derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação
NO20055531L (no) Preparat for forbedret kognisjon og hukommelse
BR0211119A (pt) Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
DK1885382T3 (da) Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af cardiovaskulære tilstande
NO20073337L (no) Fremgangsmater for behandling av andedrettssykdommer ved anvendelse av antagonister av interleukin-1 reseptor type 1
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
NO20082216L (no) Terapeutisk vaksine
WO2006009726A3 (en) Substituted urea derivatives for treating cardiac diseases
DK1608350T3 (da) Fremgangsm der til forebyggelse, behandling og diagnosticering af lidelser af proteinaggregation
NO20072223L (no) Glykogenfosforylaseinhibitor forbindelser med farmsoytiske preparater av disse
NO20060020L (no) 3-fluorpiperidiner som NMDA/NR2B-antagonister
NO20064964L (no) Behandling av svekket respiratorisk funksjon
WO2020092618A9 (en) Methods of treating depression, anxiety and sexual dysfunction using the compound pimavanserin
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
NO20064951L (no) 1,3,4-oksadiazol-2-oner som PPAR delta-modulatorer og deres anvendelse
DE602006017574D1 (de) Als protein-kinase-inhibitoren nutzbare benzimidazole
NO20045215L (no) Anvendelse av tio-oxindolderivater for behandling av hudlidelser
NZ590839A (en) Treatment of pulmonary arterial hypertension
WO2008086452A3 (en) Treatment and prevention of alzheimer's disease
WO2007023072A3 (en) Use of ambroxol for the treatment of rhinovirus infections

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees